All Articles

Ballislife Drink is giving NBA stars like Coby White equity, not just cash. But the real story is the struggling energy firm, Ozop, betting its future on it.

A silent, massive shift has occurred in life insurance, with private capital now controlling nearly one-fifth of the industry. What does this mean for your financial safety net?

As UFP Industries preps its Q2 report, investors weigh a tough Q1 against strategic acquisitions and a resilient housing market. A critical moment awaits.

A new report reveals how cybercriminals are weaponizing the World Cup, using AI and sophisticated lures to exploit global excitement and target employees.

From private label obscurity to a DTC contender, a 60-year-old cleaning brand is betting on sustainable tech and e-commerce to recapture the American home.

A new nonprofit is using tax-exempt bonds to fight healthcare consolidation. Is Anoma Cancer Collective's model a lifeline for local cancer care?

An AI infrastructure firm just used its own tech to design safer painkillers, tackling the liver toxicity risks of common drugs. What does this mean for pharma?

As 'forever chemical' rules tighten, Allonnia's new PFAS Prepare+ service aims to de-risk cleanup by selling data-driven certainty in a complex market.

After a disastrous quarter, less-lethal tech firm Byrna Technologies is cutting operations, acquiring a rival, and betting its future on a major marketing blitz.

A new India-US health alliance leverages 5G and AI, signaling a shift where private foundations and tech infrastructure are redrawing the map of global health.

Gartner has named eInfochips a 'Pioneer' in Physical AI Services, validating the critical shift from software to tangible, real-world automated systems.

As OneSpan prepares its Q2 2026 report, the results will offer more than financial data; they will signal the health of the burgeoning digital trust economy.

AI can now find hidden heart risks in old CT scans, a market set to boom. But as doctors warn, the code is the easy part; the human factor is not.

A new lawsuit alleges Microsoft's "best-in-class" AI was a facade, concealing deep-rooted flaws in Copilot that misled investors and hit its bottom line.

Panda Express is bringing back its viral Hot Orange Chicken. We dive into the 'swicy' trend, fan-driven demand, and the strategy behind this comeback.

A new partnership between Sam's Club and Weight Watchers makes holistic health more accessible, especially for those on GLP-1s. Is this the future of retail?

An e-commerce logistics firm is making a bold play for the entertainment world, investing in a K-pop tour while building an AI-driven content empire.

A biotech firm just printed kidney and liver tissue in space for the first time, proving orbital manufacturing isn't science fiction, but our medical future.

In a strategic move, PMSI pairs its founder's vision with a veteran CEO's operational prowess. We explore how this transition aims to solve deep-seated industry problems.

Vera Therapeutics just secured its first drug approval. Now, it's bringing in a regulatory heavyweight. We deconstruct the strategy behind the move.